On March 14, 2022, the VYNE Therapeutics Inc. named Tyler Zeronda as the Chief Financial Officer and Treasurer of the Company effective immediately. Mr. Zeronda, 36, has been serving as the Company's Interim Chief Financial Officer and Treasurer since June 2021. Prior to his appointment as Interim Chief Financial Officer, Mr. Zeronda served as Vice President of Finance of the Company.